Corporate News

New health rules throw Kenya’s Aids budget into distress

Share Bookmark Print Email
Email this article to a friend

Submit Cancel
Rating
A sample of antiretrovirals. Financing treatment in Kenya is expected to be complicated by the WHO’s recommendation that a key drug be withdrawn from the market. Photo/FILE

A sample of antiretrovirals. Financing treatment in Kenya is expected to be complicated by the WHO’s recommendation that a key drug be withdrawn from the market. Photo/FILE 

By BEATRICE GACHENGE  (email the author)
Email this article to a friend

Submit Cancel


Posted  Monday, December 21  2009 at  00:00

This means that the 15 countries that receive PEPfAR funds including Kenya will see no increase on their budget.

Share This Story
Share

“Health is not a priority for the government as it is highly dependent on donor finding. The major risk Kenya faces with such a model is that we are left venerable at such a time when the global crisis has threatened such funding,” said Eve Odete, Pan Africa Policy Officer- Social Justice, Oxfam GB.

Analysts say PEPfAR has been affected due to other hard pressing priorities for the American government.

« Previous Page 1 | 2 | 3